Literature DB >> 28570085

Use of Bloodborne Pathogens Exposure Control Plans in Private Dental Practices: Results and Clinical Implications of a National Survey.

Angela K Laramie1, Helene Bednarsh2, Beverly Isman3, James M Boiano4, Susan H McCrone5.   

Abstract

Dental healthcare workers (DHWs) are at risk for occupational exposure to bloodborne pathogens (BBPs). The Occupational Safety and Health Administration Bloodborne Pathogens Standard requires employers to have a written exposure control plan (ECP) detailing methods and means to reduce and manage occupational BBP exposures. Because little information is available on whether ECPs are created and used, the National Institute for Occupational Safety and Health and the Organization for Safety, Asepsis and Prevention conducted an online survey to determine if dental practices had an ECP, whether present ECPs had the necessary components, and if impediments existed to prevent having an ECP in place. Respondents were primarily from nonfranchised practices (69%) and dentists who owned the practice (63%). Seventy-two percent of survey participants had an ECP, and 20% were unaware of any federal requirements for an ECP prior to the survey. Engineering controls were used by many practices, although the type varied. Fifteen percent of practices did not offer the hepatitis B vaccine for employees. The survey revealed many dental practices were unaware of or were lacking required elements of the ECP. Findings from this survey indicate DHWs would benefit from increased education regarding methods to prevent occupational exposures to BBPs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28570085      PMCID: PMC5795264     

Source DB:  PubMed          Journal:  Compend Contin Educ Dent        ISSN: 1548-8578


  11 in total

1.  Dental students and bloodborne pathogens: occupational exposures, knowledge, and attitudes.

Authors:  Julie E Myers; Ronnie Myers; Mary E Wheat; Michael T Yin
Journal:  J Dent Educ       Date:  2012-04       Impact factor: 2.264

2.  Preventing percutaneous injuries among dental health care personnel.

Authors:  Jennifer L Cleveland; Laurie K Barker; Eve J Cuny; Adelisa L Panlilio
Journal:  J Am Dent Assoc       Date:  2007-02       Impact factor: 3.634

3.  Hepatitis C in hospital employees with needlestick injuries.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; Y Nakano; S Furuta; K Nishioka; R H Purcell; H J Alter
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

4.  Underreporting of bloodborne exposures in a dental school clinic.

Authors:  Evelyn Cuny; Terry E Hoover; Jeffrey S Kirk
Journal:  J Dent Educ       Date:  2011-04       Impact factor: 2.264

Review 5.  Risk taking by health care workers.

Authors:  L M Sulzbach-Hoke
Journal:  Clin Nurse Spec       Date:  1996-01       Impact factor: 1.067

6.  Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial.

Authors:  G F Grady; V A Lee; A M Prince; G L Gitnick; K A Fawaz; G N Vyas; M D Levitt; J R Senior; J T Galambos; T E Bynum; J W Singleton; B F Clowdus; K Akdamar; R D Aach; E I Winkelman; G M Schiff; T Hersh
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

7.  Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity.

Authors:  B G Werner; G F Grady
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

Review 8.  Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview.

Authors:  D M Bell
Journal:  Am J Med       Date:  1997-05-19       Impact factor: 4.965

9.  Hepatitis C virus infection in medical personnel after needlestick accident.

Authors:  T Mitsui; K Iwano; K Masuko; C Yamazaki; H Okamoto; F Tsuda; T Tanaka; S Mishiro
Journal:  Hepatology       Date:  1992-11       Impact factor: 17.425

10.  Percutaneous injuries among dental professionals in Washington State.

Authors:  Syed M Shah; Anwar T Merchant; James A Dosman
Journal:  BMC Public Health       Date:  2006-10-30       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.